Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: fatigue attention and dopaminergic signaling
Also known as: Ladasten
Bromantane, marketed in Russia as Ladasten, is an adamantane-derived actoprotector with stimulant and anxiolytic-like effects in older Russian literature. The largest cited clinical program enrolled 728 patients with asthenic disorders at 50-100 mg/day for 28 days, but reporting and methodology do not match modern registered international trials. Mechanistic claims about dopamine synthesis are predominantly preclinical. Intranasal use is a newer community/vendor practice, not a clinical-trial route.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Russian clinical literature and review, current vendors, and labeled community evidence
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
50-100 mg/day
Context: Russian multicenter asthenia program; limited modern trial documentation
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.
9-36 mg/day
Context: community and vendor-reported only; not a validated clinical protocol
Route safety: Unvalidated community report. Do not convert this amount to another route or treat it as a clinically established protocol.
Source status: No direct community citation is attached to this amount.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.
Current retail formats include 50 mg 60-count capsules and bulk powder from 1 g upward. Reddit use clusters around 9 mg-per-spray intranasal products, but that route has no clinical PK or safety trial.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.